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The imidazotetrazinones are a new group of broad
spectrum antitumour agents which undergo
decomposition in aqueous solution to yield a
triazene species (Stevens et al., 1984), which is
probably responsible for the antitumour activity
(Horgan & Tisdale, 1984, 1985). During an
investigation into this group of compounds it was
observed that the methyl derivative, 8-carbamoyl-3-
methylimidazo-[5,1-d]- 1,2,3,5-tetrazin-4-(3H)-one
(CCRG 81045; M&B 39831; Figure 1), besides
being an effective inhibitor of tumour growth in
vitro and in vivo, caused the appearance of
erythroid characteristics in the human
erythroleukaemia cell line K562 (Tisdale, 1985).
Similar results were obtained with an aromatic
methyltriazene, but neither the ethyltriazene nor
CCRG 82019 (Figure 1) were effective in this
respect, even at concentrations causing an
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Figure 1 Structure of chemicals used in the study.
equivalent effect on cell growth to methyl
analogues. The predominant mechanism by which
this group of compounds produce cell death is
considered to be by alkylation of DNA (Gibson et
al., 1984a), although the molecular lesion
responsible for cytotoxicity has not yet been
elucidated. In the chloroethyl series cross-linking is
though to occur from an initial alkylation on the
06-position of guanine since an 06-methylguanine
repair proficient cell line (Mer+) has been shown to
be less sensitive to the cytotoxic effect of these
agents than a repair deficient (Mer-) cell line
(Gibson et al., 1984b).
There is now a general agreement that ADP-
ribosylation participates in some way in DNA
excision repair in nucleated cells (Shall, 1982). It
has also been suggested that poly(adenosine
diphosphate ribose) (poly(ADP-Rib)), synthesis is
related to cell differentiation (Williams &
Johnstone, 1983). Thus inhibitors of nuclear
(adenosine diphosphate)ribosyl transferase (poly
(ADPRT)) have been shown to reversibly block
chick myoblast differentiation in vitro (Farzaneh
et al., 1982) and the mitogen-induced differentia-
tion of human peripheral-blood T lymphocytes
(Johnstone & Williams, 1982), and there are
marked changes in endogenous poly(ADP-Rib)
levels during differentiation of HL60 cells with
dimethylsulphoxide (DMSO) (Kani et al., 1982).
This suggests a relationship between damage to
DNA and induction of differentiation. In this
study the variation in poly(ADPRT) activity has
been investigated after treatment of K562 cells
with imidazotetrazinones in an effort to dissect out
the relative contributions to growth inhibition and
differentiation.
Nicotinamide-[adenine-2,8-3H]dinucleotide (Sp.
act. 2.8Cimmol-1) was purchased from New
England Nuclear, Southampton, UK. Tissue culture
medium was purchased from Gibco, Europe Ltd.,
Scotland. K562 were maintained in RPMI 1640
media containing 10% foetal calf serum under an
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atmosphere of 10% CO2 in air. Drug solutions
were made up in 10% DMSO at 10-times the
required concentration such that the final
concentration of DMSO in the culture medium did
not exceed 0.15%. At this concentration DMSO
does not induce erythroid differentiation in K562
cells (Rowley et al., 1981) or inhibit cell growth, or
affect poly(ADPRT) activity (Pulito et al., 1983).
For cell growth studies cells were seeded at
5 x 104cellsml- and cell number was enumerated
daily with a Coulter counter. The cells were
sedimented by centrifugation (300g, 10min) prior
to measurement of erythroid differentiation which
was scored by benzidine staining. 3,3',5,5'-
Tetramethylbenzidine (2mgml-1 in 1% acetic acid)
was mixed with 30% hydrogen peroxide
(20yulml-1) and added directly to an equal volume
(10pI) of cell suspension. After 5min cells were
scored as benzidine positive (blue) using an
Olympus phase contrast microscope at 40 x.
Viability was determined by trypan blue exclusion.
The method of Halldorsson et al. (1978) was
used for the preparation of permeabilized cells.
Sedimented cells were washed with 10ml of Pucks
saline A at 0°C and resuspended in 200pl of
hypotonic solution (9mM HEPES, pH7.8, 5mM
dithiothreitol, 4.5% (w/v) dextran, 1 mm EGTA,
4.5mm MgCl2) at a cell density of 2-
3 x 107 cellsml-I for at least 30min.
For the assay of poly(ADP-ribose)polymerase,
permeabilized cells (100 1) were added to 100I 1 of
assay buffer (100mm Tris-HCl, pH8, 2mm MgCl2,
8.2mm NaCl, 1 mm 2-mercaptoethanol and
0.2mm EDTA) at 37°C and agitated for 20min
prior to the addition of [3H]-NAD (final
concentration 5pCiml-1, 0.33mM). The reaction
was terminated by the addition of 2ml of ice-cold
10% trichloroacetic acid. After 30min or more at
0°C the precipitated cells were filtered onto glass
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fibre discs, washed 6 times with 5% trichloroacetic
acid and once with acetone. The filters were dried
at 70°C for 1 h and the precipitated material was
solubilized with 200,u1 hyamine hydroxide and the
radioactivity counted in PCS solubilizer (Hopkin &
Williams) after overnight incubation in the dark.
Control experiments showed no significant
degradation of NAD during the period of
incorporation into poly(ADP-ribose).
The activity of poly(ADPRT) in permeabilized
cells increased linearly with reaction times up to
60min of incubation (Figure 2) and was directly
proportional to the cell number in the assay (data
not shown). Treatment of K562 cells with CCRG
81045 caused a concentration and time-dependent
increase in poly(ADPRT) activity determined in
permeabilized cells, which was maximal 2 days after
drug addition and thereafter decreased (Figure 3).
This increase in poly(ADPRT) activity preceded the
induction of haemoglobin synthesizing cells in the
cultures, which was not observable until 3 days
after drug addition and thereafter increased linearly
until day 5 (Figure 4). The frequency of production
of haemoglobin producing cells increased with
concentration of CCRG 81045 up to a maximum of
73.5gm and thereafter decreased as toxicity
developed. Induction of benzidine-positive cells by
CCRG 81045 was accompanied by an inhibition of
cell growth. The maximal increase in poly(ADPRT)
produced by CCRG 81045 (Figure 3) was linearly
related to the percentage inhibition of cell growth
attained (Figure 5). Elevation of poly(ADPRT) by
CCRG 81045 also occurred after incubation with
permeabilized cells in vitro, although higher drug
concentrations were required than in suspension
cultures (Table I).
Unlike CCRG 81045 the ethyl analogue, CCRG
82019 (Figure 1), produced growth inhibition of
K562 cells without a concomitant increase in the
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Figure 2 Rate of incorporation of [3H]NAD+ into permeabilized K562 cells.a)
cJ
E
0
Q
CD
-5
E
a. a
0a
0-
250
0 200
4-
0
150
en
a,
0
C.)
50
Time (d) after drug addition
Figure 3 Activity of poly(ADPRT) in K562 cells
treated with O(V), 24.5(x), 49(0) or 73.5(O)pM
of CCRG 81045. Enzyme incubations were carried out
for 60min at 37°C with 1pCi [3H]NAD+ per assay.
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Figure 4 Kinetics of appearance of benzidine-positive
K562 cells cultured in the absence ( x) or in the
presence of 4.9(0), 24.5(0), 36.8(V) or 73.5(V) /M of
CCRG 81045. The percentage benzidine-positive cells
was evaluated on a minimum of 200 cells counted in a
haemocytometer and was repeated 4 times.
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Figure 5 Relationship between the elevation in
poly(ADPRT) activity 2 days after treatment of K562
cells with CCRG 81045(x) or CCRG 82019(0) and
the percentage inhibition of cell growth, determined
from the linear part of the growth curves.
Table I Effect of CCRG 81045 on
poly(ADPRT) activity in vitro.
Concentration Activity
mM (% ofcontrol+s.e.)
0 100
0.5 108+4
1 114+2
5 173+5
CCRG 81045 was preincubated with
permeabilized cells for 20min prior to
the addition of [3H]NAD+.
number of benzidine-positive cells in the cultures.
However, CCRG 82019 also caused an elevation in
poly(ADPRT) activity which was maximal 2 days
after drug treatment. The elevation ofpoly(ADPRT)
by CCRG 82019 was also proportional to the
extent of growth inhibition and lay on the same line
CCRG 81045 (Figure 5).
Measurement of poly(ADPRT) activity in
permeabilized cells is likely to reflect the situation
in vivo more closely than studies on isolated nuclei,
because the DNA will be less damaged. Previous
studies have shown an inverse correlation between
DNA synthesis and poly(ADPRT) activity (Berger
et al., 1978). Thus inhibition of DNA synthesis with
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agents such as cytosine arabinoside was associated
with an increase in the intrinsic activity of
poly(ADPRT). A similar correlation has been
observed in the present study between the induction
of poly(ADPRT) activity by two imidazotetra-
zinones and the inhibition of cell growth. In several
systems it has been demonstrated that DNA
breakage increased the activity of this enzyme
(Shall, 1982). Studies on the mechanism of
decomposition of the imidazotetrazinones suggest
the formation of a triazene metabonate (Stevens et
al., 1984; Horgan & Tisdale, 1985) capable of
alkylating DNA. In the case of CCRG 81045 and
CCRG 82019 (Figure 1) alkylation of DNA might
be expected to follow a similar pattern to that of
the nitrosoureas, agents capable of causing single
strand breaks in parental DNA (Erickson et al.,
1978). Streptozotocin, a glucose derivative of
methylnitrosourea has been shown to activate
poly(ADPRT) 3-fold (Whish et al., 1975), a level
similar to that observed with CCRG 81045 and
CCRG 82019. Methylnitrosourea has also been
shown to increase enzyme activity in permeabilized
cells (Skidmore et al., 1979). However, in contrast
with the present study, most of these agents have
been used at supralethal concentrations.
Although CCRG 81045 causes an increase in
poly(ADPRT) activity in K562 cells it is unlikely
that this is related to the induction of haemoglobin
synthesis by this agent. A related drug CCRG
82019 incapable of altering phenotypic expression
produces a similar increase in enzyme activity and
the increase produced by both agents is
proportional to the extent of cell growth inhibition.
It thus seems likely that alterations in
poly(ADPRT) activity produced by this group of
drugs is related to DNA damage and that other
mechanisms are involved in the alteration of gene
expression.
This work was supported by a grant from the Cancer
Research Campaign.
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